Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 23, 2020

SELL
$0.48 - $1.03 $21,276 - $45,656
-44,327 Closed
0 $0
Q2 2020

Aug 06, 2020

BUY
$0.37 - $0.61 $16,400 - $27,039
44,327 New
44,327 $23,000

Others Institutions Holding VTGN

About VistaGen Therapeutics, Inc.


  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $623M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Sitrin Capital Management LLC Portfolio

Follow Sitrin Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sitrin Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sitrin Capital Management LLC with notifications on news.